Hagen Brett R
SEC CIK 1681782 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KLRS | Kalaris Therapeutics, Inc. | CAO | 0 | — | $442.5K | 40 | 2022-01-18 | 2026-03-20 |
Most active insiders at KLRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samsara Opportunity Fund, L.P. | 10% | $5.00M | — |
| 2 | AKKARAJU SRINIVAS | Dir, 10% | $1.18M | — |
| 3 | Hagen Brett R | CAO | — | $12.9K |
Transactions 40
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-23 | 2026-03-20 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $6.72 | -1,915 | 0 | -100% | -$12.9K |
| 2025-03-27 | 2025-03-26 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $8.97 | -907 | 1,925 | -32% | -$8,136 | |
| 2025-02-24 | 2025-02-21 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $10.08 | -96 | 2,832 | -3% | -$967.68 | |
| M | 2025-01-27 | 2025-01-23 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $9.50 | -36 | 2,932 | -1% | -$342.16 |
| 2025-01-13 | 2025-01-10 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.44 | -332 | 68.2K | -0.5% | -$146.08 | |
| 2024-11-20 | 2024-11-19 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.55 | -554 | 68.5K | -0.8% | -$304.70 | |
| 2024-11-06 | 2024-11-05 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.86 | -1,655 | 69.1K | -2% | -$1,423 | |
| M | 2024-10-23 | 2024-10-21+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.775 | -965 | 70.7K | -1% | -$747.84 |
| 2024-10-04 | 2024-10-03 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.81 | -301 | 71.7K | -0.4% | -$243.81 | |
| 2024-08-20 | 2024-08-19 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.76 | -544 | 72.0K | -0.8% | -$413.44 | |
| 2024-08-07 | 2024-08-05 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.73 | -1,692 | 72.5K | -2% | -$1,235 | |
| M | 2024-07-23 | 2024-07-19+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.745 | -960 | 74.7K | -1% | -$715.19 |
| 2024-07-03 | 2024-07-02 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.72 | -304 | 75.2K | -0.4% | -$218.88 | |
| 2024-05-21 | 2024-05-17 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.75 | -541 | 75.5K | -0.7% | -$405.75 | |
| 2024-05-07 | 2024-05-03 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.8 | -1,597 | 76.0K | -2% | -$1,278 | |
| M | 2024-04-23 | 2024-04-19+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.75 | -953 | 77.6K | -1% | -$714.75 |
| 2024-04-04 | 2024-04-02 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.77 | -281 | 78.6K | -0.4% | -$216.37 | |
| 2024-02-22 | 2024-02-20 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.7 | -494 | 78.9K | -0.6% | -$345.80 | |
| 2024-02-09 | 2024-02-08 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.67 | -11.2K | 79.3K | -12% | -$7,470 | |
| 2024-02-06 | 2024-02-05 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.67 | -5,792 | 90.5K | -6% | -$3,881 | |
| 2024-01-25 | 2024-01-23 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.67 | -901 | 96.3K | -0.9% | -$603.67 | |
| 2024-01-08 | 2024-01-04 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.64 | -310 | 97.2K | -0.3% | -$198.40 | |
| 2024-01-02 | 2023-12-27 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $0.74 | -28.3K | 97.5K | -23% | -$21.0K | |
| 2023-11-21 | 2023-11-17 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $1.63 | -403 | 125.8K | -0.3% | -$656.89 | |
| M | 2023-10-23 | 2023-10-19+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $1.56 | -715 | 126.6K | -0.6% | -$1,115 |
| 2023-10-05 | 2023-10-03 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $1.98 | -222 | 127.0K | -0.2% | -$439.56 | |
| 2023-08-21 | 2023-08-17 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $2.50 | -1,653 | 127.2K | -1% | -$4,132 | |
| M | 2023-07-21 | 2023-07-19+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $3.46 | -684 | 129.2K | -0.5% | -$2,363 |
| 2023-06-13 | 2023-06-09 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $5.64 | -5,045 | 129.5K | -4% | -$28.5K | |
| M | 2023-04-21 | 2023-04-19+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $3.67 | -697 | 134.6K | -0.5% | -$2,558 |
| D | 2023-02-03 | 2023-02-02 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | A - Grant | $0.00 | +61.2K | 135.3K | +83% | $0 |
| M | 2023-01-23 | 2023-01-19+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $5.09 | -1,895 | 74.3K | -2% | -$9,647 |
| M | 2022-11-14 | 2022-11-10+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $8.14 | -24.0K | 75.9K | -24% | -$195.2K |
| A | 2022-10-26 | 2022-10-20 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $9.36 | -345 | 113.2K | -0.3% | -$3,229 |
| M | 2022-10-24 | 2022-10-19+ | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $8.43 | -13.7K | 101.9K | -12% | -$115.3K |
| 2022-08-17 | 2022-08-16 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | A - Grant | $0.00 | +20.0K | 113.6K | +21% | $0 | |
| D | 2022-07-06 | 2022-07-01 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | A - Grant | $0.00 | +10.5K | 93.6K | +13% | $0 |
| 2022-04-22 | 2022-04-20 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $6.68 | -276 | 80.4K | -0.3% | -$1,844 | |
| D | 2022-04-04 | 2022-01-18 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | A - Grant | $0.00 | +17.4K | 80.6K | +28% | $0 |
| 2022-01-24 | 2022-01-20 | KLRS | Kalaris Therapeutics, Inc. | Hagen Brett R | CAO | S - Sale | $8.75 | -1,563 | 63.2K | -2% | -$13.7K |
Purchase Sale Sale after option exercise All abbreviations